Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNOCAT: Sodium Nitrite in Out-of-Hospital Cardiac Arrest
NCT03452917Phase 3Completed
- Sponsor
- University of Washington
- Start
- Feb 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium nitrite in cardiac arrest (SCA) (3 arms), sponsored by University of Washington. Primary endpoint: Proportion of Patients Surviving to Hospital Admission at 24 hours. Started Feb 2018; status: completed.
02
Drugs
sodium nitrite
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT03452917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452917.